|
FIREFLEYE [Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study]
|
n = 113
|
NCT04004208, Bayer
|
2021, long-term follow-up underway
|
Stahl A, Azuma N, Wu WC, et al. Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: Results from the FIREFLEYE randomized phase 3 study. Eye (Lond). 2024;38(8):1444-1453. https://www.nature.com/articles/s41433-023-02919-9
|
|